ReviewCurrent opinion in virology2021

Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection.

Koen Vandyck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.